NASDAQ: SHPG       Shire Plc Ads
Last Price Today's Change   Day's Range   Trading Volume
177.05   +1.34 (0.76%)  176.93 - 178.44  671,732


Avg Volume (4 weeks):988,202
4 Weeks Range:168.26 - 178.60
52 Weeks Range:161.09 - 209.22
Average Price Target: 247.00
Price Target Upside/Downside: +69.95


No recent Headlines for this stock.

Business Background

Shire plc is a biotech company focused on serving people with rare diseases and other specialized conditions. The Company's segment is engaged in research, development, licensing, manufacturing, marketing, distribution and sale of specialist medicines. It focuses its development resources on projects in various therapeutic areas (TAs), including Neuroscience, Ophthalmology, Hematology, Oncology, Immunology, Gastrointestinal (GI)/Metabolic/Endocrinology Diseases. Its Hematology products include ADVATE (Antihemophilic Factor (Recombinant)), ADYNOVATE/ADYNOVI (Antihemophilic Factor (Recombinant), PEGylated)), RIXUBIS (Coagulation Factor IX (Recombinant)), VONVENDI (von Willebrand factor (Recombinant)) and FEIBA (Anti-Inhibitor Coagulant Complex). Its Genetic Diseases products include CINRYZE (C1 esterase inhibitor (human)), FIRAZYR (icatibant), ELAPRASE (idursulfase), REPLAGAL (agalsidase alfa) and VPRIV (velaglucerase alfa).

  Be the first to like this.


4391  2684  586  662 

Top 10 Active Counters
 BAC 24.215+0.585 
 JNUG 4.36-0.89 
 BABY 40.85+0.25 
 AKS 6.50-0.62 
 NUGT 8.08-1.28 
 SPY 238.70+1.53 
 GDX 22.135-1.065 
 ABX 17.10-1.94 
 FCX 12.945+0.715 
 XLF 23.95+0.27 
Partners & Brokers